MRPL44
protein-codingmitochondrial ribosomal protein L44, the group of Large subunit mitochondrial ribosomal proteins|Mitochondrial ribosomal proteins
Gene summary
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *MRPL44* and autosomal recessive primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of September 7, 2022. The MRPL44 gene encodes mitochondrial ribosomal protein L44, which is a component of the large subunit (39S) of the mitochondrial ribosome. The *MRPL44 *gene was first reported in relation to primary mitochondrial disease in 2013 (PMID: 23315540). While various names have been given to the constellation of features seen in those with *MRPL44*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *MRPL44* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included four unique variants (3 missense, 1 frameshift) identified in six unrelated cases from four publications (PMIDs: 23315540, 25797485, 34140213, 33742325). The mechanism of pathogenicity appears to be loss of function. Of note, the c.467T>G, p.Leu156Arg variant has been identified in every case reported to date and may be a founder variant in the European population, although this has not been confirmed. This gene-disease relationship is also supported by a biochemical function (mitochondrial translation) shared with other genes associated with primary mitochondrial disease, functional alteration studies in patient cells showing impaired synthesis of mitochondrial proteins, and rescue of the mitochondrial protein levels and large mitochondrial ribosomal subunit assembly in patient cells following expression of the wild type protein (PMIDs: 33340416, 33742325, 23315540). In summary, there is definitive evidence to support the relationship between *MRPL44* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 7, 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0014162
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014162
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014162
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014162
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal
Intervention: Cardiovascular
Rationale: Individuals have been reported as teenagers with hypertrophic cardiomyopathy (as well as with infantile-onset hyptertrophic cardiomyopathy), and surveillance for cardiomyopathy (eg, with echocardiography/electrocardiography) may allow early detection and medical treatment of disease manifestations
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MRPL44 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022915.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 42 | 1 | 43 | |||
| missense | 3 | 78 | 6 | 1 | 88 | |
| nonsense | 1 | 1 | 3 | 5 | ||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | 4 | 6 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 2 | 6 | 87 | 48 | 2 | 145 |
Highest pathogenic variant AF is 0.00033827193
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_075066.1 | 4 | MANE Select | |
| Ensembl | ENSP00000258383.3 | 4 | MANE Select | |
| Ensembl | ENSP00000595282.1 | 4 | Standard | |
| Ensembl | ENSP00000647494.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mitochondrial translation initiation
- Translation
- Metabolism of proteins
- Mitochondrial translation elongation
- Mitochondrial translation termination
Biological Process
- RNA processing
- production of siRNA involved in RNA interference
- primary miRNA processing
- pre-miRNA processing
- mitochondrial translational elongation
Molecular Function
- RNA binding
- double-stranded RNA binding
- ribonuclease III activity
- protein binding
Cellular Component
- nucleus
- mitochondrion
- mitochondrial inner membrane
- mitochondrial large ribosomal subunit
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000258383
- Coding exons
- 4
- Length
- 10311
- Individuals with no LoFs
- 125709
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 39
- Defined
- 125748
- p
- 0.000155
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0785 | 177 | 180 | 0.984 | 0.00000874 | 2138 |
| Missense (PolyPhen) | 47 | 57.584 | 0.81619 | 611 | ||
| Synonymous | 0.206 | 68 | 70.2 | 0.969 | 0.00000350 | 673 |
| Loss of Function | -0.162 | 13 | 12.4 | 1.05 | 5.21e-7 | 162 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00012 | 0.00011 | rare |
| South Asian | 0.00046 | 0.00046 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the 39S subunit of mitochondrial ribosome. May have a function in the assembly/stability of nascent mitochondrial polypeptides exiting the ribosome. {ECO:0000269|PubMed:23315540}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 16 (COXPD16) [MIM:615395]: An autosomal recessive, mitochondrial disorder characterized by hypertrophic cardiomyopathy, liver steatosis, and decreased levels of mitochondrial complexes I and IV in heart and skeletal muscle. {ECO:0000269|PubMed:23315540}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- LoFtool
- 0.815
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 34.6
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.894
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |